Navigation Links
High-quality DNA/RNA from Microorganisms in Environmental Samples
Date:10/15/2008

THOROLD, ON, Oct. 15 /PRNewswire/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids and protein purification, today announced the launch of two new kits for the isolation of nucleic acids from environmental samples, the Soil DNA Isolation Kit and the Water RNA/DNA Purification Kit. These kits are ideal for environmental microbiological studies, and provide high quality, inhibitor-free DNA and/or RNA that can be used in various downstream applications such as PCR.

The Soil DNA Isolation Kit allows for the isolation of genomic DNA from various microorganisms found in all types of soil samples, including soil with high humic acid content such as compost and manure. The purified DNA is of the highest quality and is fully compatible with downstream PCR applications, as humic substances and other PCR inhibitors are removed during the extraction. Norgen's Water RNA/DNA Purification Kit is designed for the isolation of genomic DNA and total RNA from the microorganisms found in water. The organic-free extracted RNA and DNA are of the highest quality, concentrated and free from PCR inhibitors.

"Our new kits for the isolation of DNA and RNA from environmental microorganisms represent an exciting addition to our line of high quality products. We listened to our customers' feedback that they routinely encounter high levels of PCR inhibiton in nucleic acids isolated from environmental samples. I am very pleased that our scientists rose to the challenge and designed high quality kits that purify nucleic acids free of PCR inhibitors. We are confident that microbiologists will be satisfied with the quality and quantity of DNA isolated from soil and water samples with these kits and will get meaningful PCR amplification results. We have found that these kits out-perform the leading environmental kits on the market," said Dr. Haj-Ahmad, President & CEO of Norgen Biotek.

About Norgen Biotek Corp.

Norgen is a privately-held Canadian biotechnology company specializing in the development, manufacturing and marketing of sample preparation. We develop innovative best-in-class kits to purify DNA, RNA, microRNA and proteins from variety of sample using our proprietary technology. Norgen is open to various modality of business opportunity.


'/>"/>
SOURCE Norgen Biotek Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
2. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
3. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
4. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
5. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
6. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
7. Carbon hoofprint: Cows supplemented with rbST reduce agricultures environmental impact
8. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
9. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
10. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
11. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , Feb. 20, 2017  Atrius Health and ... entered into an agreement to develop a cloud ... By providing a holistic view of the multiple ... Watson Cognitive Insights could be designed to support ... Health is an innovative nonprofit healthcare organization with ...
(Date:2/18/2017)... Feb 17, 2017 Research and Markets has ... Report" report to their offering. ... The report provides separate comprehensive analytics for ... , and Rest of World. Annual estimates and forecasts are provided ... is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)...  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today presented ... drug candidates, PTG-100 and PTG-200, at the 12 ... Colitis Organization (ECCO).  The ECCO congress is being ... from February 15 – 18, 2017. ... drug candidates PTG-100 and PTG-200. PTG-100, a potential ...
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
Breaking Biology Technology:
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):